Bio-Techne Corp
NASDAQ:TECH
Bio-Techne Corp
Net Income (Common)
Bio-Techne Corp
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bio-Techne Corp
NASDAQ:TECH
|
Net Income (Common)
$224.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
7%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Net Income (Common)
$568.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
69%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
See Also
What is Bio-Techne Corp's Net Income (Common)?
Net Income (Common)
224.2m
USD
Based on the financial report for Dec 31, 2023, Bio-Techne Corp's Net Income (Common) amounts to 224.2m USD.
What is Bio-Techne Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%
Over the last year, the Net Income (Common) growth was -14%. The average annual Net Income (Common) growth rates for Bio-Techne Corp have been 9% over the past three years , 18% over the past five years , and 7% over the past ten years .